Terms: = Testicular cancer AND AXIN1, LA16c-314G4_3, 8312, ENSG00000103126, O15169, AXIN, MGC52315 AND Prognosis
650 results:
1. Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium.
Bührer E; D'Haese D; Daugaard G; de Wit R; Albany C; Tryakin A; Fizazi K; Stahl O; Gietema JA; De Giorgi U; Cafferty FH; Hansen AR; Tandstad T; Huddart RA; Necchi A; Sweeney CJ; Garcia-Del-Muro X; Heng DYC; Lorch A; Chovanec M; Winquist E; Grimison P; Feldman DR; Terbuch A; Hentrich M; Bokemeyer C; Negaard H; Fankhauser C; Shamash J; Vaughn DJ; Sternberg CN; Heidenreich A; Collette L; Gillessen S; Beyer J
Eur J Cancer; 2024 May; 202():114042. PubMed ID: 38564927
[TBL] [Abstract] [Full Text] [Related]
2. Survival differences in non-seminoma testis cancer patients according to race/ethnicity.
Incesu RB; Barletta F; Tappero S; Piccinelli ML; Garcia CC; Morra S; Scheipner L; Tian Z; Saad F; Shariat SF; Ahyai S; Longo N; Chun FKH; de Cobelli O; Terrone C; Briganti A; Tilki D; Graefen M; Karakiewicz PI
Cancer Epidemiol; 2024 Apr; 89():102538. PubMed ID: 38377946
[TBL] [Abstract] [Full Text] [Related]
3. A population-based validation of the IGCCCG Update Consortium for survival in metastatic non-seminoma testis cancer.
Incesu RB; Morra S; Scheipner L; Barletta F; Baudo A; Garcia CC; Tappero S; Piccinelli ML; Tian Z; Saad F; Shariat SF; de Cobelli O; Terrone C; Chun FKH; Carmignani L; Briganti A; Ahyai S; Longo N; Tilki D; Graefen M; Karakiewicz PI
Jpn J Clin Oncol; 2024 May; 54(5):592-598. PubMed ID: 38369557
[TBL] [Abstract] [Full Text] [Related]
4. Oncological and endocrinological outcomes for children and adolescents with testicular and ovarian sex cord-stromal tumors. Results of the TGM13 National Registry.
Fuentes C; Ouldbey Y; Orbach D; Sudour-Bonnange H; Verité C; Rome A; Dumesnil C; Thebaud E; Hameury F; Dijoud F; Chabaud S; Cote MD; Fresneau B; Faure-Conter C
Pediatr Blood Cancer; 2024 Apr; 71(4):e30864. PubMed ID: 38259036
[TBL] [Abstract] [Full Text] [Related]
5. Epidemiology, Management, and Survival Outcomes of Germ Cell cancer in Southern Portugal: A Population-Based Study (2008-2012).
Brito M; Ramos M; Silva JP; Câmara G; Mayer A; Miranda A; Coelho JLP; Moreira A; Esteves S
Clin Genitourin Cancer; 2024 Feb; 22(1):e170-e177.e1. PubMed ID: 38061978
[TBL] [Abstract] [Full Text] [Related]
6. Pediatric Sertoli-Leydig Cell Tumors of the Ovary: An Integrated Study of Clinicopathological Features, Pan-cancer-Targeted Next-generation Sequencing and Chromosomal Microarray Analysis From a Single Institution.
Yang B; Chour W; Salazar CG; Zamiara P; Schmidt RJ; Raca G; Shillingford N; Zhou S; Warren M; Parham DM; Pawel B; Wang LL
Am J Surg Pathol; 2024 Feb; 48(2):194-203. PubMed ID: 37946548
[TBL] [Abstract] [Full Text] [Related]
7. Sertoli-Leydig cell tumor: a clinicopathological analysis in a comprehensive, national cohort.
Bekker P; Miland-Samuelsen AR; Smerdel MP; Schnack TH; Lauszus FF; Karstensen SH
Int J Gynecol Cancer; 2023 Dec; 33(12):1921-1927. PubMed ID: 37907261
[TBL] [Abstract] [Full Text] [Related]
8. Origin and outcome of metastatic tumours to the testes: a nationwide study.
Woortman C; van Leenders GJLH; Hugen N; van Oijen MGH; Nagtegaal ID
BJU Int; 2024 Mar; 133(3):305-313. PubMed ID: 37877215
[TBL] [Abstract] [Full Text] [Related]
9. Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database.
Lauritsen J; Sauvé N; Tryakin A; Jiang DM; Huddart R; Heng DYC; Terbuch A; Winquist E; Chovanec M; Hentrich M; Fankhauser CD; Shamash J; Del Muro XG; Vaughn D; Heidenreich A; Sternberg CN; Sweeney C; Necchi A; Bokemeyer C; Bandak M; Jandari A; Collette L; Gillessen S; Beyer J; Daugaard G
Br J Cancer; 2023 Nov; 129(11):1759-1765. PubMed ID: 37777577
[TBL] [Abstract] [Full Text] [Related]
10. Distinct patterns of copy number alterations may predict poor outcome in central nervous system germ cell tumors.
Takami H; Satomi K; Fukuoka K; Nakamura T; Tanaka S; Mukasa A; Saito N; Suzuki T; Yanagisawa T; Sugiyama K; Kanamori M; Kumabe T; Tominaga T; Tamura K; Maehara T; Nonaka M; Asai A; Yokogami K; Takeshima H; Iuchi T; Kobayashi K; Yoshimoto K; Sakai K; Nakazato Y; Matsutani M; Nagane M; Nishikawa R; Ichimura K
Sci Rep; 2023 Sep; 13(1):15760. PubMed ID: 37735187
[TBL] [Abstract] [Full Text] [Related]
11. Excellent survival in relapsed stage I testicular cancer.
Speicher P; Fankhauser CD; Lorch A; Ardizzone D; Helnwein S; Hoch D; Hermanns T; Beyer J; Akhoundova D
BMC Cancer; 2023 Sep; 23(1):870. PubMed ID: 37715132
[TBL] [Abstract] [Full Text] [Related]
12. Dose comparison of robustly optimized intensity modulated proton therapy (IMPT) vs IMRT and VMAT photon plans for testicular seminoma.
Rønde HS; Kronborg C; Høyer M; Hansen J; Bak ME; Agergaard SN; Als AB; Agerbæk M; Lauritsen J; Meidahl Petersen P; Dysager L; Kallehauge JF
Acta Oncol; 2023 Oct; 62(10):1222-1229. PubMed ID: 37683054
[TBL] [Abstract] [Full Text] [Related]
13. Conditional survival of stage III non-seminoma testis cancer patients.
Incesu RB; Barletta F; Tappero S; Morra S; Garcia CC; Scheipner L; Piccinelli ML; Tian Z; Saad F; Shariat SF; de Cobelli O; Ahyai S; Chun FKH; Longo N; Terrone C; Briganti A; Tilki D; Graefen M; Karakiewicz PI
Urol Oncol; 2023 Oct; 41(10):435.e11-435.e18. PubMed ID: 37558516
[TBL] [Abstract] [Full Text] [Related]
14. [Clinicopathological analysis of nuclear protein in testis midline carcinoma].
Zhang SH; Hu CF; Gao LN; Qiao JF; Li X; Shi SS
Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):808-813. PubMed ID: 37527985
[No Abstract] [Full Text] [Related]
15. [Diagnosis and treatment of malignant mesothelioma of the tunica vaginalis testis: a series of 7 cases].
Huang KB; Cao Y; Yao K; Zhou FJ; Liu ZW; Li XD
Zhonghua Wai Ke Za Zhi; 2023 Sep; 61(9):812-817. PubMed ID: 37491176
[No Abstract] [Full Text] [Related]
16. [Clinicopathologic characteristics and prognostic analysis of testicular diffuse large B-cell lymphoma].
Wang Y; Shi ZY; Shi Q; Wang S; Zhang MC; Shen R; He Y; Qiu HL; Yi HM; Dong L; Wang L; Cheng S; Xu PP; Zhao WL
Zhonghua Xue Ye Xue Za Zhi; 2023 Apr; 44(4):321-327. PubMed ID: 37357002
[No Abstract] [Full Text] [Related]
17. Retroperitoneal tumour resection in fifteen consecutive cases: Single centre experience.
Novotný R; Donátová Z; Büchler T; Kristek J; Froněk J; Janousek L
Rozhl Chir; 2023; 102(4):154-158. PubMed ID: 37344195
[TBL] [Abstract] [Full Text] [Related]
18. Pan-cancer analysis of G6PD carcinogenesis in human tumors.
Liu B; Fu X; Du Y; Feng Z; Chen R; Liu X; Yu F; Zhou G; Ba Y
Carcinogenesis; 2023 Aug; 44(6):525-534. PubMed ID: 37335542
[TBL] [Abstract] [Full Text] [Related]
19. Analysis of prognostic factors and establishment of prognostic model for primary mediastinal germ cell tumors: a case controlled study.
Leng C; Cui Y; Mai Z; Chen R; Yuan J; Wang K; Wen J; Fu J; Liu Q
Int J Surg; 2023 Sep; 109(9):2574-2584. PubMed ID: 37222675
[TBL] [Abstract] [Full Text] [Related]
20. Clinical Features and Survival Outcomes in Children and Adolescents With Malignant Mediastinal Germ Cell Tumors Based on Surveillance, Epidemiology, and End Results Database Analysis.
Wu P; Yang Y; Yu Z; Zhao L; Feng S
J Surg Res; 2023 Aug; 288():362-371. PubMed ID: 37062232
[TBL] [Abstract] [Full Text] [Related]
[Next]